Novacyt S.A. (ALNOV.PA) Stock Price

€0.484 2.3%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    4

  • Fundamental

    2

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Novacyt S.A., AI stock picks, stock alerts and much more.

Sign up

ALNOV.PA AI Stock Analysis

AI stock analysis for ALNOV.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Novacyt S.A. (ALNOV.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Novacyt S.A. (ALNOV.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novacyt S.A. (ALNOV.PA), currently trading at €0.484, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ALNOV.PA

LSE

Similar Stocks

EAPI.PA Euroapi S.A.
EAPI.PA		 €3.2
2.9%
6
ALEMG.PA Euromedis Groupe
ALEMG.PA		 €4.21
0.5%
6
ALMDT.PA Median Technologies SA
ALMDT.PA		 €2.65
2.7%
5
ALDMS.PA Diagnostic Medical Systems S.A.
ALDMS.PA		 €1.43
0.4%
6
IBAB.BR Ion Beam Applications SA
IBAB.BR		 €12.1
0.8%
5

News

Novacyt (LON:NCYT) Stock Price Down 4.8% – Here’s Why

Novacyt (LON:NCYT) Stock Price Down 4.8% – Here’s Why
January 29, 2025. ETF Daily News
Novacyt (LON:NCYT) Trading 0.2% Higher – Here’s What Happened

Novacyt (LON:NCYT) Trading 0.2% Higher – Here’s What Happened
January 3, 2025. ETF Daily News
Novacyt (LON:NCYT) Trading 12.8% Higher

Novacyt (LON:NCYT) Trading 12.8% Higher
September 19, 2024. ETF Daily News
Novacyt (LON:NCYT) Shares Down 8.7%

Novacyt (LON:NCYT) Shares Down 8.7%
September 12, 2024. ETF Daily News

ALNOV.PA Alternative Data

Web Traffic

Novacyt S.A. receives an estimated 5958 monthly visitors to novacyt.com.

  • Web Traffic

    5958

  • Change from Previous Month

    12.5%

  • 3 Month Change

    86.4%

  • YoY Change

    86.4%

Twitter Followers

Novacyt S.A. has 2,769 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.

  • Twitter Followers

    2769

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.3%

  • YoY Change

    0.3%

Facebook Engagement

Novacyt S.A. has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Youtube Subscribers

Novacyt S.A. has 677 subscribers on its main Youtube channel, down by -0.3% over the last month.

  • Youtube Subscribers

    677

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    0.9%

Job Postings

Novacyt S.A. has an estimated 1 open job postings, which is down -50% over the last month.

  • Job Postings

    1

  • Daily Change

    0%

  • 1 Month Change

    50%

  • 3 Month Change

    75%

LinkedIn Followers

8,508 are following Novacyt S.A. on LinkedIn, up by 1.7% over the last month.

  • LinkedIn Followers

    8508

  • Daily Change

    1.7%

  • 1 Month Change

    1.7%

  • 3 Month Change

    9.3%

LinkedIn Employees

According to LinkedIn, Novacyt S.A. has 60 employees, down by -4.8% over the last month.

  • LinkedIn Employees

    60

  • Daily Change

    4.8%

  • 1 Month Change

    4.8%

  • 3 Month Change

    10.4%

  • YoY Change

    10.4%

Business Outlook

According to employee reviews, the business outlook among employees at Novacyt S.A. is 37 out of 100 (bearish).

  • Business Outlook

    37

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Novacyt S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

Novacyt S.A. was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

ALNOV.PA Financials

ALNOV.PA Key Metrics

  • Total Revenue

    €9.6M

  • Net Income

    €0

  • Earnings per Share

    €0

  • Free cash flow

    -€4.9M

  • EBITDA

    €9.6M

  • EBITDA Ratio

    1

  • Total Assets

    €133.8M

ALNOV.PA 2-year Revenue & Income
ALNOV.PA 2-year Free Cash Flow

ALNOV.PA Technicals

ALNOV.PA SMA
ALNOV.PA RSI

FAQ

What's the current price of Novacyt S.A. (ALNOV.PA) Stock?
The price of an Novacyt S.A. (ALNOV.PA) share is €0.484.

What's the market cap of Novacyt S.A.?
The current market cap of Novacyt S.A. is 34.2M.

Should I buy or sell ALNOV.PA?
Novacyt S.A. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Novacyt S.A. is better viewed as a hold or accumulate position while waiting for further developments.

Is Novacyt S.A. a good investment?
The current analysis of Novacyt S.A.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Novacyt S.A.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Novacyt S.A. (ALNOV.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Novacyt S.A. stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Novacyt S.A. (ALNOV.PA) that investors often compare it to?
Novacyt S.A. (ALNOV.PA) is often compared to similar stocks such as Euroapi S.A., Euromedis Groupe, Median Technologies SA, Diagnostic Medical Systems S.A. and Ion Beam Applications SA.

What is the forecast for Novacyt S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novacyt S.A.'s stock price to be around €0.468 in 2026. Starting from the current price of €0.484, this represents a 3.3% change in price, indicating a neutral outlook for the stock.

How to buy Novacyt S.A. (ALNOV.PA) Stock?
Novacyt S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novacyt S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.